Frequency of non-Hodgkin lymphoma subtypes by country and region
| . | Central and South America . | CSA total % (N) . | North America % (N) . | ||||
|---|---|---|---|---|---|---|---|
| Argentina % (n) . | Brazil % (n) . | Chile % (n) . | Guatemala % (n) . | Peru % (n) . | |||
| B-cell neoplasms | |||||||
| Diffuse large B-cell lymphoma | 25.9* (48) | 40.6 (78) | 38.9 (75) | 45.1† (87) | 50.6*† (83) | 40.0† (371) | 29.2 (116) |
| Follicular lymphoma, all grades | 34.1* (63) | 19.8† (38) | 25.4 (49) | 10.4*† (20) | 11.6*† (19) | 20.4† (189) | 33.8 (134) |
| Marginal zone B-cell lymphoma, MALT type | 5.9 (11) | 9.4 (18) | 10.4 (20) | 4.1 (8) | 4.3 (7) | 6.9 (64) | 6.3 (25) |
| Mantle cell lymphoma | 8.1 (15) | 3.6 (7) | 5.7 (11) | 6.2 (12) | 0.6*† (1) | 5.0 (46) | 6.8 (27) |
| Chronic lymphocytic leukemia/ small lymphocytic lymphoma | 5.4 (10) | 6.3 (12) | 3.6 (7) | 1.6 (3) | 1.8 (3) | 3.8 (35) | 4.8 (19) |
| Burkitt lymphoma | 1.6 (3) | 2.1 (4) | 2.1 (4) | 6.7*† (13) | 1.8 (3) | 2.9 (27) | 0.8 (3) |
| Marginal zone B-cell lymphoma, nodal/splenic | 4.3 (8) | 2.1 (4) | 1.6 (3) | 2.1 (4) | 3.0 (5) | 2.6 (24) | 1.8 (7) |
| Precursor B-lymphoblastic leukemia / lymphoma | 0.0 (0) | 1.6 (3) | 0.0 (0) | 6.2*† (12) | 4.3† (7) | 2.4† (22) | 0.5 (2) |
| High-grade B-cell lymphoma, Burkitt-like | 0.0 (0) | 0.5 (1) | 0.5 (1) | 1.0 (2) | 0.6 (1) | 0.5 (5) | 2.5 (10) |
| Hairy cell leukemia | 0.0 (0) | 2.1 (4) | 0.0 (0) | 0.5 (1) | 0.0 (0) | 0.5 (5) | 0.0 (0) |
| Plasmacytoma | 0.5 (1) | 0.5 (1) | 0.0 (0) | 1.6 (3) | 0.0 (0) | 0.5 (5) | 0.0 (0) |
| Lymphoplasmacytic lymphoma | 1.1 (2) | 0.0 (0) | 0.0 (0) | 0.0 (0) | 0.0 (0) | 0.2 (2) | 1.5 (6) |
| Unclassifiable low-grade B-cell lymphoma | 0.5 (1) | 1.0 (2) | 0.0 (0) | 0.5 (1) | 1.2 (2) | 0.6 (6) | 1.3 (5) |
| Unclassifiable high-grade B-cell lymphoma | 0.5 (1) | 1.0 (2) | 0.5 (1) | 1.0 (2) | 1.2 (2) | 0.9 (8) | 1.3 (5) |
| Subtotal | 88.1 (163) | 90.6 (174) | 88.6 (171) | 87.0 (168) | 81.1 (133) | 87.3 (809) | 90.4 (359) |
| T-cell neoplasms | |||||||
| Peripheral T-cell lymphomas | 9.2 (17) | 5.7 (11) | 6.7 (13) | 3.1 (6) | 9.8 (16) | 6.8 (63) | 5.3 (21) |
| Extranodal NK/T-cell lymphoma, nasal type | 0.5 (1) | 1.0 (2) | 2.6† (5) | 7.8*† (15) | 2.4 (4) | 2.9† (27) | 0.0 (0) |
| Precursor T-lymphoblastic leukemia / lymphoma | 1.6 (3) | 1.6 (3) | 1.6 (3) | 2.1 (4) | 0.6 (1) | 1.5 (14) | 2.0 (8) |
| Adult T-cell leukemia / lymphoma | 0.0 (0) | 0.0 (0) | 0.5 (1) | 0.0 (0) | 5.5*† (9) | 1.1† (10) | 0.0 (0) |
| Mycosis fungoides | 0.5 (1) | 1.0 (2) | 0.0 (0) | 0.0 (0) | 0.6 (1) | 0.4 (4) | 2.3 (9) |
| Subtotal | 11.9 (22) | 9.4 (18) | 11.4 (22) | 13.0 (25) | 18.9 (31) | 12.7 (118) | 9.6 (38) |
| Total | 185 | 192 | 193 | 193 | 164 | 927 | 397 |
| . | Central and South America . | CSA total % (N) . | North America % (N) . | ||||
|---|---|---|---|---|---|---|---|
| Argentina % (n) . | Brazil % (n) . | Chile % (n) . | Guatemala % (n) . | Peru % (n) . | |||
| B-cell neoplasms | |||||||
| Diffuse large B-cell lymphoma | 25.9* (48) | 40.6 (78) | 38.9 (75) | 45.1† (87) | 50.6*† (83) | 40.0† (371) | 29.2 (116) |
| Follicular lymphoma, all grades | 34.1* (63) | 19.8† (38) | 25.4 (49) | 10.4*† (20) | 11.6*† (19) | 20.4† (189) | 33.8 (134) |
| Marginal zone B-cell lymphoma, MALT type | 5.9 (11) | 9.4 (18) | 10.4 (20) | 4.1 (8) | 4.3 (7) | 6.9 (64) | 6.3 (25) |
| Mantle cell lymphoma | 8.1 (15) | 3.6 (7) | 5.7 (11) | 6.2 (12) | 0.6*† (1) | 5.0 (46) | 6.8 (27) |
| Chronic lymphocytic leukemia/ small lymphocytic lymphoma | 5.4 (10) | 6.3 (12) | 3.6 (7) | 1.6 (3) | 1.8 (3) | 3.8 (35) | 4.8 (19) |
| Burkitt lymphoma | 1.6 (3) | 2.1 (4) | 2.1 (4) | 6.7*† (13) | 1.8 (3) | 2.9 (27) | 0.8 (3) |
| Marginal zone B-cell lymphoma, nodal/splenic | 4.3 (8) | 2.1 (4) | 1.6 (3) | 2.1 (4) | 3.0 (5) | 2.6 (24) | 1.8 (7) |
| Precursor B-lymphoblastic leukemia / lymphoma | 0.0 (0) | 1.6 (3) | 0.0 (0) | 6.2*† (12) | 4.3† (7) | 2.4† (22) | 0.5 (2) |
| High-grade B-cell lymphoma, Burkitt-like | 0.0 (0) | 0.5 (1) | 0.5 (1) | 1.0 (2) | 0.6 (1) | 0.5 (5) | 2.5 (10) |
| Hairy cell leukemia | 0.0 (0) | 2.1 (4) | 0.0 (0) | 0.5 (1) | 0.0 (0) | 0.5 (5) | 0.0 (0) |
| Plasmacytoma | 0.5 (1) | 0.5 (1) | 0.0 (0) | 1.6 (3) | 0.0 (0) | 0.5 (5) | 0.0 (0) |
| Lymphoplasmacytic lymphoma | 1.1 (2) | 0.0 (0) | 0.0 (0) | 0.0 (0) | 0.0 (0) | 0.2 (2) | 1.5 (6) |
| Unclassifiable low-grade B-cell lymphoma | 0.5 (1) | 1.0 (2) | 0.0 (0) | 0.5 (1) | 1.2 (2) | 0.6 (6) | 1.3 (5) |
| Unclassifiable high-grade B-cell lymphoma | 0.5 (1) | 1.0 (2) | 0.5 (1) | 1.0 (2) | 1.2 (2) | 0.9 (8) | 1.3 (5) |
| Subtotal | 88.1 (163) | 90.6 (174) | 88.6 (171) | 87.0 (168) | 81.1 (133) | 87.3 (809) | 90.4 (359) |
| T-cell neoplasms | |||||||
| Peripheral T-cell lymphomas | 9.2 (17) | 5.7 (11) | 6.7 (13) | 3.1 (6) | 9.8 (16) | 6.8 (63) | 5.3 (21) |
| Extranodal NK/T-cell lymphoma, nasal type | 0.5 (1) | 1.0 (2) | 2.6† (5) | 7.8*† (15) | 2.4 (4) | 2.9† (27) | 0.0 (0) |
| Precursor T-lymphoblastic leukemia / lymphoma | 1.6 (3) | 1.6 (3) | 1.6 (3) | 2.1 (4) | 0.6 (1) | 1.5 (14) | 2.0 (8) |
| Adult T-cell leukemia / lymphoma | 0.0 (0) | 0.0 (0) | 0.5 (1) | 0.0 (0) | 5.5*† (9) | 1.1† (10) | 0.0 (0) |
| Mycosis fungoides | 0.5 (1) | 1.0 (2) | 0.0 (0) | 0.0 (0) | 0.6 (1) | 0.4 (4) | 2.3 (9) |
| Subtotal | 11.9 (22) | 9.4 (18) | 11.4 (22) | 13.0 (25) | 18.9 (31) | 12.7 (118) | 9.6 (38) |
| Total | 185 | 192 | 193 | 193 | 164 | 927 | 397 |